The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation
Albumin to gamma-glutamyltransferase ratio (AGR) is a newly developed biomarker for the prediction of patients’ prognosis in solid tumors. The purpose of the study was to establish a novel AGR-based nomogram to predict tumor prognosis in patients with early-stage HCC undergoing radiofrequency ablati...
Guardado en:
Autores principales: | Wenfeng Liu, Feng Zhang, Bing Quan, Miao Li, Shenxin Lu, Jinghuan Li, Rongxin Chen, Xin Yin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/04b8b6c504724e51af0820fcbda3435b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Postoperative neutrophil-to-lymphocyte ratio change predicts survival of patients with small hepatocellular carcinoma undergoing radiofrequency ablation.
por: Jiaqiang Dan, et al.
Publicado: (2013) -
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
por: Bin Chai, et al.
Publicado: (2021) -
Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era.
por: Tan To Cheung, et al.
Publicado: (2014) -
Prognostic value of pharmacotherapy in patients with atrial fibrillation after radiofrequency ablation
por: M. S. Brynza, et al.
Publicado: (2021) -
Serum Gamma-Glutamyltransferase Levels Predict the Development of Cerebral Infarction in the Korean Population
por: Lee SM, et al.
Publicado: (2021)